<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: And The Next Pharma Plant To Close Will Be&#8230;</title>
	<atom:link href="http://www.pharmalot.com/2008/07/and-the-next-pharma-plant-to-close-will-be/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/07/and-the-next-pharma-plant-to-close-will-be/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:12:41 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Annette Kreuger VP Pharma-Biotech Group Industrialinfo.com</title>
		<link>http://www.pharmalot.com/2008/07/and-the-next-pharma-plant-to-close-will-be/#comment-367640</link>
		<dc:creator>Annette Kreuger VP Pharma-Biotech Group Industrialinfo.com</dc:creator>
		<pubDate>Thu, 24 Jul 2008 13:19:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14782#comment-367640</guid>
		<description>At the Industrialinfo.com website, another recent article can be found referencing a new plant construction-
"Pharmaceutical-Biotech Construction Update: 31 New Facilities Open Doors in First Half of 2008"</description>
		<content:encoded><![CDATA[<p>At the Industrialinfo.com website, another recent article can be found referencing a new plant construction-<br />
&#8220;Pharmaceutical-Biotech Construction Update: 31 New Facilities Open Doors in First Half of 2008&#8243;</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Annette Kreuger VP Pharmaceutical-Biotech Group</title>
		<link>http://www.pharmalot.com/2008/07/and-the-next-pharma-plant-to-close-will-be/#comment-367639</link>
		<dc:creator>Annette Kreuger VP Pharmaceutical-Biotech Group</dc:creator>
		<pubDate>Thu, 24 Jul 2008 13:02:29 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14782#comment-367639</guid>
		<description>It is important to remember that the "fat lady has not sung yet"...I am monitoring over $22 billion in current active capital industry projects across North America. As I wrote in my original article, this is a natural prograssion within an industry of unbridled growth. It is still growing.
...and in the case of Puerto Rico, I am in the process of writing a full-feature article on just what the island is doing to retain and grow the industry.</description>
		<content:encoded><![CDATA[<p>It is important to remember that the &#8220;fat lady has not sung yet&#8221;&#8230;I am monitoring over $22 billion in current active capital industry projects across North America. As I wrote in my original article, this is a natural prograssion within an industry of unbridled growth. It is still growing.<br />
&#8230;and in the case of Puerto Rico, I am in the process of writing a full-feature article on just what the island is doing to retain and grow the industry.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jeffrey Clark, CEO of Beaker.com - The Online Community for Life Sciences Professionals</title>
		<link>http://www.pharmalot.com/2008/07/and-the-next-pharma-plant-to-close-will-be/#comment-367619</link>
		<dc:creator>Jeffrey Clark, CEO of Beaker.com - The Online Community for Life Sciences Professionals</dc:creator>
		<pubDate>Thu, 24 Jul 2008 04:25:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14782#comment-367619</guid>
		<description>Puerto Rico is the saddest of all these.  So many pharmaceutical companies took their operations offshore in the 90's thinking this was the permanent solution to their quest for manufacturing efficiency.  Now, they are abandoning that market quickly, leaving a scar behind as the only proof that they were ever there.</description>
		<content:encoded><![CDATA[<p>Puerto Rico is the saddest of all these.  So many pharmaceutical companies took their operations offshore in the 90&#8217;s thinking this was the permanent solution to their quest for manufacturing efficiency.  Now, they are abandoning that market quickly, leaving a scar behind as the only proof that they were ever there.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.193 seconds -->

